Ardelyx Ownership | Who Owns Ardelyx?
Ardelyx Ownership Summary
Ardelyx is owned by 59.72% institutional investors, 1.72% insiders, and 38.55% retail investors. Janus henderson group is the largest institutional shareholder, holding 11.13% of ARDX shares. Delaware Small Cap Core I is the top mutual fund, with 3.09% of its assets in Ardelyx shares.
ARDX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Ardelyx | 59.72% | 1.72% | 38.55% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Janus henderson group | 25.95M | 11.13% | $192.14M |
Blackrock | 17.55M | 7.53% | $130.06M |
Vanguard group | 13.66M | 5.86% | $101.19M |
State street | 11.97M | 5.13% | $88.66M |
Macquarie group | 6.90M | 2.96% | $51.13M |
Eventide asset management | 6.67M | 2.86% | $49.40M |
Geode capital management | 5.47M | 2.35% | $40.54M |
Millennium management | 3.20M | 1.37% | $23.73M |
Morgan stanley | 3.05M | 1.31% | $22.57M |
Voloridge investment management | 2.89M | 1.24% | $21.39M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Lion point capital, lp | 856.67K | 11.57% | $6.35M |
Oracle investment management | 1.49M | 10.29% | $11.03M |
Propel bio management | 924.58K | 4.44% | $6.85M |
Knott david m jr | 772.87K | 2.29% | $5.73M |
Clay northam wealth management | 232.38K | 1.31% | $1.72M |
Eventide asset management | 6.67M | 0.85% | $49.40M |
Redmile group | 1.88M | 0.84% | $13.94M |
Pekin hardy strauss | 531.66K | 0.54% | $3.94M |
Rubric capital management lp | 1.82M | 0.35% | $13.46M |
Simplify asset management | 598.00K | 0.30% | $4.43M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Janus henderson group | 25.95M | 0.10% | 3.90M |
Macquarie group | 6.90M | 0.06% | 3.21M |
Millennium management | 3.20M | 0.01% | 1.88M |
Wells fargo & company/mn | 884.16K | 0.00% | 767.59K |
First trust advisors lp | 652.95K | 0.00% | 652.95K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Price t rowe associates inc /md/ | 1.72M | 0.00% | -2.19M |
State street | 11.97M | 0.00% | -2.12M |
Cubist systematic strategies | - | - | -1.41M |
Nuveen asset management | 2.16M | 0.00% | -1.03M |
Citigroup | 145.09K | 0.00% | -798.40K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
First trust advisors lp | 652.95K | 0.00% | 652.95K | $4.84M |
Oberweis asset management inc/ | 371.80K | 0.17% | 371.80K | $2.76M |
Exoduspoint capital management, lp | 302.15K | 0.02% | 302.15K | $2.24M |
Jones financial companies lllp | 279.81K | 0.00% | 279.81K | $2.07M |
Mirae asset global etfs | 141.34K | 0.00% | 141.34K | $1.03M |
Sold Out
Holder | Change |
---|---|
Zrc wealth management | -15.00 |
Nelson, van denburg & campbell wealth management group | -44.00 |
Bell investment advisors | -59.00 |
Ica group wealth management | -80.00 |
Stephens consulting | -179.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 210 | 2.94% | 140,893,765 | -2.01% | 59 | 1.57% | 98 | -9.26% | 68 | 13.33% |
Jun 30, 2024 | 203 | 4.10% | 143,779,910 | 1.88% | 61 | 1.49% | 108 | -1.82% | 59 | 3.51% |
Mar 31, 2024 | 195 | 12.72% | 141,131,953 | 3.06% | 64 | 1.70% | 110 | 1.85% | 57 | 72.73% |
Dec 31, 2023 | 173 | 8.80% | 136,945,020 | 8.86% | 61 | 1.79% | 108 | 31.71% | 33 | -13.16% |
Sep 30, 2023 | 159 | 4.61% | 125,804,194 | -0.79% | 58 | 1.56% | 82 | -7.87% | 38 | 2.70% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Delaware Small Cap Core I | 7.32M | 3.09% | 1.68M |
Vanguard Total Stock Mkt Idx Inv | 7.05M | 2.97% | 11.50K |
SPDR® S&P Biotech ETF | 6.56M | 2.77% | 72.53K |
iShares Russell 2000 ETF | 5.97M | 2.52% | -13.44K |
Janus Henderson Global Life Sciences D | 4.64M | 1.97% | -3.21K |
Janus Henderson Global Life Sciences | 4.58M | 1.93% | -427.47K |
Eventide Healthcare & Life Sciences I | 4.09M | 1.74% | -147.12K |
Vanguard Institutional Extnd Mkt Idx Tr | 3.56M | 1.50% | -10.14K |
Janus Henderson Glb Life Scn I2 USD | 3.40M | 1.44% | 15.63K |
Janus Global Life Science AUSD | 3.40M | 1.44% | -228.28K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 10, 2024 | RAAB MICHAEL | President & CEO | Sell | $131.62K |
Nov 25, 2024 | RAAB MICHAEL | President & CEO | Sell | $134.48K |
Nov 20, 2024 | Williams Laura A | Chief Medical Officer | Sell | $35.32K |
Nov 20, 2024 | Rosenbaum David P. | Chief Development Officer | Sell | $10.75K |
Nov 20, 2024 | Rosenbaum David P. | Chief Development Officer | Sell | $23.69K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 1 | 14 |
2024 Q3 | - | 18 |
2024 Q2 | - | 26 |
2024 Q1 | - | 13 |
2023 Q4 | - | 18 |
ARDX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools